Results 71 to 80 of about 14,382 (155)

Ueber Biguanid [PDF]

Berichte der deutschen chemischen Gesellschaft, 1879
openaire   +1 more source

Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database. [PDF]

Diabetes Obes Metab
Aoyama K, Okada A, Kaneko H, Azegami T, Suzuki Y, Meguro S, Fujiu K, Takeda N, Morita H, Node K, Yamauchi T, Nangaku M, Takeda N, Yasunaga H, Hayashi K.   +14 more
europepmc   +1 more source

Environmental factors capable of broadly interfering with nutritional lifespan extension paradigms. [PDF]

iScience
Li S, Stuhr NL, Ahsan F, Zhou Y, Yerevanian A, Rotti J, Dao K, Jain M, Soukas AA.   +8 more
europepmc   +1 more source

ARYL BIGUANIDES [PDF]

Chemical & Engineering News Archive, 1949
openaire   +1 more source

Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51. [PDF]

Cell Death Dis
Xiao D, Yao J, Yang X, Xie Y, Zhou X, Li D, Peng M, Wang W, Zou H, Yang X.   +9 more
europepmc   +1 more source

Dangers of biguanides [PDF]

Practical Diabetes International, 1986
openaire   +1 more source

Comparative Effects of Dulaglutide and Semaglutide on Renal Function Decline and Proteinuria Reduction in Diabetic Patients: A Retrospective Cohort Study. [PDF]

J Clin Med
Sue YM, Lu DE, Chang TI, Chen CY, Chen CH, Hsu SC, Chu YL, Huang NJ, Chen TH, Lin FY, Shih CM, Huang PH, Hsieh HL, Liu CT.   +13 more
europepmc   +1 more source

Effect of treatment duration on the associations between three modern antidiabetic drugs and survival outcomes of lung cancer in China. [PDF]

Front Mol Biosci
Chen Z, Wang X, Zhang Z, Yang L, Lei C, Di Y, Huang Y, Li Y.   +7 more
europepmc   +1 more source

Trends in the Management of Patients with Type 2 Diabetes Mellitus by Japanese Practitioners. [PDF]

Diabetes Ther
Arai K, Nishikawa T, Yuasa S, Hirao K, Mori H.   +4 more
europepmc   +1 more source

Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d'Ivoire, 2023: A Secondary Analysis. [PDF]

Clinicoecon Outcomes Res
Attia Konan AR, Koffi K, Hounsa Alla EA, Sindé AJM, Sackou Kouakou JG.   +4 more
europepmc   +1 more source